Literature DB >> 30361863

A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: Mapping the way forward.

Geoffrey de Brouwer1, Arina Fick1, Brian H Harvey1,2, De Wet Wolmarans3.   

Abstract

Rodent marble-burying behavior in the marble-burying test (MBT) is employed as a model or measure to study anxiety- and compulsive-like behaviors or anxiolytic and anticompulsive drug action. However, the test responds variably to a range of pharmacological interventions, and little consensus exists regarding specific methodologies for its execution. Regardless, the test is widely applied to investigate the effects of pharmacological, genetic, and behavioral manipulations on purported behaviors related to the said neuropsychiatric constructs. Therefore, in the present review we attempt to expound the collective translational significance of the MBT. We do this by (1) reviewing burying behavior as a natural behavioral phenotype, (2) highlighting key aspects of anxiety and obsessive-compulsive disorder from a translational perspective, (3) reviewing the history and proof of concept of the MBT, (4) critically appraising potential methodological confounds in execution of the MBT, and (5) dissecting responses of the MBT to various pharmacological interventions. We conclude by underlining that the collective translational value of the MBT will be strengthened by contextually valid experimental designs and objective reporting of data.

Entities:  

Keywords:  Animal model; Anxiety; Marble-burying test; Methodology; Obsessive–compulsive disorder; Review; Validity

Mesh:

Substances:

Year:  2019        PMID: 30361863     DOI: 10.3758/s13415-018-00653-4

Source DB:  PubMed          Journal:  Cogn Affect Behav Neurosci        ISSN: 1530-7026            Impact factor:   3.282


  193 in total

1.  Effect of Hypericum perforatum on marble-burying by mice.

Authors:  L L Skalisz; V Beijamini; R Andreatini
Journal:  Phytother Res       Date:  2004-05       Impact factor: 5.878

2.  Obsessive-compulsive disorder.

Authors:  Jonathan S Abramowitz; Steven Taylor; Dean McKay
Journal:  Lancet       Date:  2009-08-08       Impact factor: 79.321

Review 3.  Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder.

Authors:  Mostafa El Mansari; Pierre Blier
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-01-20       Impact factor: 5.067

4.  Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

Authors:  M Navarro; E Hernández; R M Muñoz; I del Arco; M A Villanúa; M R Carrera; F Rodríguez de Fonseca
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

5.  Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice.

Authors:  Jeffrey M Welch; Jing Lu; Ramona M Rodriguiz; Nicholas C Trotta; Joao Peca; Jin-Dong Ding; Catia Feliciano; Meng Chen; J Paige Adams; Jianhong Luo; Serena M Dudek; Richard J Weinberg; Nicole Calakos; William C Wetsel; Guoping Feng
Journal:  Nature       Date:  2007-08-23       Impact factor: 49.962

Review 6.  The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder.

Authors:  David W Evans; Marc D Lewis; Emily Iobst
Journal:  Brain Cogn       Date:  2004-06       Impact factor: 2.310

7.  Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder.

Authors:  Schaun Korff; Dan J Stein; Brian H Harvey
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-29       Impact factor: 5.067

8.  Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test.

Authors:  Toshiharu Shimazaki; Michihiko Iijima; Shigeyuki Chaki
Journal:  Eur J Pharmacol       Date:  2004-10-06       Impact factor: 4.432

9.  Behavioral phenotyping of neuropeptide S receptor knockout mice.

Authors:  Dee M Duangdao; Stewart D Clark; Naoe Okamura; Rainer K Reinscheid
Journal:  Behav Brain Res       Date:  2009-07-29       Impact factor: 3.332

10.  Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice.

Authors:  Sergey V Shmelkov; Adília Hormigo; Deqiang Jing; Catia C Proenca; Kevin G Bath; Till Milde; Evgeny Shmelkov; Jared S Kushner; Muhamed Baljevic; Iva Dincheva; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; George D Yancopoulos; Ipe Ninan; Francis S Lee; Shahin Rafii
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

View more
  27 in total

1.  Ketamine induces immediate and delayed alterations of OCD-like behavior.

Authors:  Summer L Thompson; Amanda C Welch; Julia Iourinets; Stephanie C Dulawa
Journal:  Psychopharmacology (Berl)       Date:  2020-01-11       Impact factor: 4.530

2.  (S)-5-(2'-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder.

Authors:  Jessica L Armstrong; Austen B Casey; Tanishka S Saraf; Munmun Mukherjee; Raymond G Booth; Clinton E Canal
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

3.  Animal Models for OCD Research.

Authors:  Brittany L Chamberlain; Susanne E Ahmari
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 4.  Assessing negative affect in mice during abstinence from alcohol drinking: Limitations and future challenges.

Authors:  Solal Bloch; Katherine M Holleran; Thomas L Kash; Elena M Vazey; Jennifer A Rinker; Christina L Lebonville; Krysten O'Hara; Marcelo F Lopez; Sara R Jones; Kathleen A Grant; Howard C Becker; Patrick J Mulholland
Journal:  Alcohol       Date:  2022-02-15       Impact factor: 2.405

5.  Dynamic activity of interpeduncular nucleus GABAergic neurons controls expression of nicotine withdrawal in male mice.

Authors:  Paul M Klenowski; Rubing Zhao-Shea; Timothy G Freels; Susanna Molas; Andrew R Tapper
Journal:  Neuropsychopharmacology       Date:  2021-07-29       Impact factor: 7.853

6.  Epigenetic mechanisms underlying stress-induced depression.

Authors:  Luana Martins de Carvalho; Wei-Yang Chen; Amy W Lasek
Journal:  Int Rev Neurobiol       Date:  2020-09-26       Impact factor: 3.230

Review 7.  Anxiety and Alzheimer's disease: Behavioral analysis and neural basis in rodent models of Alzheimer's-related neuropathology.

Authors:  Nathan S Pentkowski; Kimberly K Rogge-Obando; Tia N Donaldson; Samuel J Bouquin; Benjamin J Clark
Journal:  Neurosci Biobehav Rev       Date:  2021-05-09       Impact factor: 9.052

8.  N6-substituated adenosine analog J4 attenuates anxiety-like behaviors in mice.

Authors:  Lee Peyton; Brandon Emanuel León; Hesham Essa; Yijuang Chern; Doo-Sup Choi
Journal:  Psychopharmacology (Berl)       Date:  2022-01-31       Impact factor: 4.415

9.  Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole.

Authors:  Mikhail V Voronin; Yulia V Vakhitova; Inna P Tsypysheva; Dmitry O Tsypyshev; Inna V Rybina; Rustam D Kurbanov; Elena V Abramova; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

10.  Digging behavior discrimination test to probe burrowing and exploratory digging in male and female mice.

Authors:  Heather L Pond; Abigail T Heller; Brian M Gural; Olivia P McKissick; Molly K Wilkinson; M Chiara Manzini
Journal:  J Neurosci Res       Date:  2021-05-28       Impact factor: 4.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.